Hub Gene Key Drug Prediction Finds Halicin, Ruxolitinib, Tofacitinib, Clenoliximab, and Baricitinib May be Key to Osteoarthritis Treatment
Along with global aging, osteoarthritis (OA) appears to have a high incidence and disability rate, which seriously affects the quality of life of patients, making age a major risk factor. However, the pathology of OA is ...
